SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
7,08 USD
0,00%
(0,00) 1 D.
10-01, 14:50:24 GMT−4 · USD
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „SHPMY“ įžvalgos...
Rinkos kapitalizacija
62,44 mlrd.
Vid. kiekis
125,00
Apimtis
0,00
52 sav. aukšta
8,23 USD
52 sav. žema
6,41 USD
Beta
0,58
Neapmokėtos akcijos
183,81 mln.
Darbuotojų skaičius
49 tūkst.
Rinkos kapitalizacija
62,44 mlrd.
Vid. kiekis
125,00
Apimtis
0,00
52 sav. aukšta
8,23 USD
52 sav. žema
6,41 USD
Beta
0,58
Neapmokėtos akcijos
183,81 mln.
Darbuotojų skaičius
49 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
www.marketscreener.com
·
prieš 30 minučių
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
Voice of Alexandria
·
prieš 55 minutes
U.S. Based Rare Earth Company Winner Water to Join SPD and Mobix Labs (Nasdaq: MOBX) National Security Matters Initiative
TradingView
·
prieš 24 minutes
Voyager Awarded $22.4M Dow Contract For Next-Gen Satellite Deployment Systems
MarketWatch
·
prieš 2 valandas
An AI ‘reality check’ may take the S&P 500 to 5,000. Here are the trades to make, this strategist says.
Profilis
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Apie „Shanghai Pharmaceuticals Holdings ADR“
Generalinis direktorius-
Darbuotojai48,6 tūkst.
Įkurta1994-01-18
Pagrindinė būstinė-
SektoriusHealth care provider
Svetainėsphchina.com